About Ascent Innovative Medicines Private Limited
Data last updated:
Ascent Innovative Medicines Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2016PTC273442. Its GSTIN is 27AAOCA2423N1ZE (Maharashtra).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It is led by directors Subodh Gupta (Managing Director) and Suresh Mahabirprasad Deora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.56 Lakh, a decline of 83% compared to the previous year. For the same year it recorded a net loss of ₹25.49 Lakh (net margin -266.5%) and EBITDA of -₹25.49 Lakh (EBITDA margin -266.5%). Revenue has declined at a compounded annual rate (CAGR) of 58% over three years and 47% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Ascent Innovative Medicines. The company has 1 deal on record (1 secondary share transfer); the latest was in October 2017.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ascentinnovative.com.
Company details
Contact details
Ascent Innovative Medicines Private Limited's registered office is in Mumbai, Maharashtra. Its website is ascentinnovative.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address54 – A Elite Auto House, Andheri Kurla Road Andheri East, Mumbai, Maharashtra, India – 400093
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of Ascent Innovative Medicines Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ascent Innovative Medicines operates one associated brand: Ascent Innovative Medicines. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Educational platform simplifying plasma-derived therapies for healthcare users. | ascentinnovative.com |
Business activity
The main business activity of Ascent Innovative Medicines is manufacturing. In detail, this covers other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities |
To see the full business activity and turnover split of Ascent Innovative Medicines Private Limited, buy the company report.
Financials of Ascent Innovative Medicines Private Limited
FY 2025 filings availableAscent Innovative Medicines Private Limited reported revenue of ₹9.56 Lakh (down 83% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 47% over five years, including a 83% fall in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹25.49 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹25.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -266.5% | ||||
| Net Profit Margin | -266.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ascent Innovative Medicines Private Limited, buy the company report.
Board of directors of Ascent Innovative Medicines Private Limited
Ascent Innovative Medicines has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subodh Gupta | Managing Director | 24 Feb 2016 | 10 Years 8 Months | Current |
| Suresh Mahabirprasad Deora Also directs: PDS Healthcare LLP, Grind Essentials Private Limited, Bombay Ampoules Private Limited and 3 more | Director | 24 Feb 2016 | 10 Years 8 Months | Current |
Auditor
Ascent Innovative Medicines Private Limited is audited by S.S.Jhujhunwala & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.S.Jhujhunwala & Co. | FY 2022 | 111926W |
Shareholding
The shareholding of Ascent Innovative Medicines Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ascent Innovative Medicines Private Limited, buy the company report.
Deals & funding
Ascent Innovative Medicines Private Limited has 1 deal on record (1 secondary share transfer); the latest was in October 2017.
To see the full deal history of Ascent Innovative Medicines Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Ascent Innovative Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ascent Innovative Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ascent Innovative Medicines Private Limited has a workforce of 8 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
GST
Ascent Innovative Medicines has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCA2423N1ZE | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ascent Innovative Medicines Private Limited, buy the company report.
Recent activity
Ascent Innovative Medicines Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Hemadri Mittadoddi ceased to be Director on 10 Feb 2021.
Frequently asked questions
Ascent Innovative Medicines is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 February 2016 (10+ years old) and is registered under CIN U74900MH2016PTC273442.
Ascent Innovative Medicines has 2 current directors:
- Subodh Gupta - Managing Director
- Suresh Mahabirprasad Deora - Director
The latest financial statements of Ascent Innovative Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Ascent Innovative Medicines is 27AAOCA2423N1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ascent Innovative Medicines is U74900MH2016PTC273442. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ascent Innovative Medicines was incorporated on 24 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Ascent Innovative Medicines has 1 deal on record (1 secondary share transfer); the latest was in October 2017.
Hemadri Mittadoddi ceased to be Director on 10 Feb 2021. Sunilendu Bhushan Roy ceased to be Director on 25 Jun 2019. Subodh Gupta ceased to be Director on 07 Mar 2019. Ascent Innovative Medicines has 5 board changes on record in total.
Ascent Innovative Medicines can be reached through the website ascentinnovative.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Ascent Innovative Medicines is at 54 – A Elite Auto House, Andheri Kurla Road Andheri East, Mumbai, Maharashtra, India – 400093.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
